Trials / Conditions / Recurrent Childhood Central Nervous System Neoplasm

Recurrent Childhood Central Nervous System Neoplasm

5 registered clinical trials studyying Recurrent Childhood Central Nervous System Neoplasm.

Status	Trial	Sponsor	Phase
Completed	Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or H NCT03220035	National Cancer Institute (NCI)	Phase 2
Completed	Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lympho NCT03213691	National Cancer Institute (NCI)	Phase 2
Completed	Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Hist NCT03233204	National Cancer Institute (NCI)	Phase 2
Completed	Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas NCT02323880	Children's Oncology Group	Phase 1
Completed	Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies NCT02116777	National Cancer Institute (NCI)	Phase 1 / Phase 2